-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Tenaya Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2024.
- Tenaya Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2025 was $3.73M, a 11.7% decline year-over-year.
- Tenaya Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2025 was $16M, a 0.06% decline year-over-year.
- Tenaya Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $16.5M, a 7.79% increase from 2023.
- Tenaya Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $15.3M, a 33.5% increase from 2022.
- Tenaya Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11.5M, a 289% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)